Mienke Rijsdijk

Dr. Mienke Rijsdijk


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2021 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
JDJacqueline F M van Dijk
Jacqueline F M van Dijk
RZRuth Zaslansky
Ruth Zaslansky
RBRegina L M van Boekel
Regina L M van Boekel
JCJuanita M Cheuk-Alam
Juanita M Cheuk-Alam
SBSara J Baart
Sara J Baart
MRMienke Rijsdijk
Mienke Rijsdijk
Background: As the population ages, the number of elderly people undergoing surgery increases. Literature on the incidence and intensity of postoperative pain in the elderly is conflicting. This study examines associations between age and pain-related patient reported outcomes and perioperative pain management in a dataset of surgical patients undergoing four common surgeries: spinal surgery, hip or knee replacement, or laparoscopic cholecystectomy. Based on the authors’ clinical experience, they hypothesize that pain scores are lower in older patients. Methods: In this retrospective cohort, study data were collected between 2010 and 2018 as part of the international PAIN OUT program. Patients filled out the International Pain Outcomes Questionnaire on postoperative day 1. Results: A total of 11,510 patients from 26 countries, 59% female, with a mean age of 62 yr, underwent one of the aforementioned types of surgery. Large variation was detected within each age group for worst pain, yet for each surgical procedure, mean scores decreased significantly with age (mean Numeric Rating Scale range, 6.3 to 7.3; β = –0.2 per decade; P ≤ 0.001), representing a decrease of 1.3 Numeric Rating Scale points across a lifespan. The interference of pain with activities in bed, sleep, breathing deeply or coughing, nausea, drowsiness, anxiety, helplessness, opioid administration on the ward, and wish for more pain treatment also decreases with age for two or more of the procedures. Across the procedures, patients reported being in severe pain on postoperative day one 26 to 38% of the time, and pain interfered moderately to severely with movement. Conclusions: The authors’ findings indicate that postoperative pain decreases with increasing age. The change is, however, small and of questionable clinical significance. Additionally, there are still too many patients, at any age, undergoing common surgeries who suffer from moderate to severe pain, which interferes with function, supporting the need for tailoring care to the individual patient. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:

19 June 2022 in British Journal of Anaesthesia
Verified
Journal Article
Open access
MDMarjelle E.C. van Driel
Marjelle E.C. van Driel
JDJacqueline F.M. van Dijk
Jacqueline F.M. van Dijk
SBSara J. Baart
Sara J. Baart
WMWinfried Meissner
Winfried Meissner
FHFrank J.P.M. Huygen
Frank J.P.M. Huygen
MRMienke Rijsdijk
Mienke Rijsdijk
Early identification of patients at risk of developing chronic postsurgical pain (CPSP) is an essential step in reducing pain chronification in postsurgical patients. We aimed to develop and validate a prognostic model for the early prediction of CPSP including pain characteristics indicating altered pain processing within 2 weeks after surgery. A prospective cohort study was conducted in adult patients undergoing orthopaedic, vascular, trauma, or general surgery between 2018 and 2019. Multivariable logistic regression models for CPSP were developed using data from the University Medical Centre (UMC) Utrecht and validated in data from the Erasmus UMC Rotterdam, The Netherlands. In the development (n=344) and the validation (n=150) cohorts, 28.8% and 21.3% of patients reported CPSP. The best performing model (area under the curve=0.82; 95% confidence interval [CI], 0.76-0.87) included preoperative treatment with opioids (odds ratio [OR]=4.04; 95% CI, 2.13-7.70), bone surgery (OR=2.01; 95% CI, 1.10-3.67), numerical rating scale pain score on postoperative day 14 (OR=1.57; 95% CI, 1.34-1.83), and the presence of painful cold within the painful area 2 weeks after surgery (OR=4.85; 95% CI, 1.85-12.68). Predictive performance was confirmed by external validation. As only four easily obtainable predictors are necessary for reliable CPSP prediction, the models are useful for the clinician to be alerted to further assess and treat individual patients at risk. Identification of the presence of painful cold within 2 weeks after surgery as a strong predictor supports altered pain processing as an important contributor to CPSP development.

4 October 2024 in Pain Practice
Verified
Journal Article
Open access
EAElisabeth J. M. Adriaansen
Elisabeth J. M. Adriaansen
JJJulien G. Jacobs
Julien G. Jacobs
LVLisette M. Vernooij
Lisette M. Vernooij
AWAlbert J. M. van Wijck
Albert J. M. van Wijck
SCSteven P. Cohen
Steven P. Cohen
MRMienke Rijsdijk
Mienke Rijsdijk
Introduction: Patients suffering from postherpetic neuralgia (PHN) report unilateral chronic pain in one or more dermatomes after an acute herpes zoster (HZ) infection. The incidence of acute HZ ranges between three and five patients per 1000 person‐years. In one out of four patients, acute HZ‐related pain will transition into PHN. PHN can be very disabling for patients and reduce quality of life. Additionally, the treatment of PHN is characterized by high failure rates. The aim of this review is to give an update on the previous practical guideline published in 2011 and revised in 2015 (published in 2019) and to provide an overview of current interventional treatment options for HZ infection and PHN.Methods: The literature on the diagnosis and treatment of HZ and PHN was systematically reviewed and summarized.Results: The most important treatment for acute HZ‐related pain is antiviral therapy within 72 h of symptom onset. Additional symptomatic treatment options are analgesic drugs according to the WHO pain ladder, tricyclic antidepressants (eg, nortriptyline), and antiepileptic drugs (eg, gabapentin). If pain is not sufficiently reduced, interventional treatment such as an epidural injection with local anesthetics and corticosteroids or pulsed radiofrequency of the dorsal root ganglion (DRG) are options. Treatment for PHN is preferably transdermal capsaicin, lidocaine, or oral drugs such as antidepressants or antiepileptics.Conclusions: Treatment of acute HZ‐related pain especially PHN is challenging. Besides the conventional treatment for PHN, interventional management is considered a new treatment option. PRF of DRG seems to be the most promising interventional management.

11 October 2012 in European journal of pain
Verified
Journal Article
Closed access
PDF file
MRMienke Rijsdijk
Mienke Rijsdijk
AWA.J.M. van Wijck
A.J.M. van Wijck
PMP.C.W. Meulenhoff
P.C.W. Meulenhoff
AKA. Kavelaars
A. Kavelaars
ITI. van der Tweel
I. van der Tweel
CKC.J. Kalkman
C.J. Kalkman

22 January 2025 in The Journal of Pain
Verified
Journal Article
Open access
MRMienke Rijsdijk
Mienke Rijsdijk
HSHidde M. Smits
Hidde M. Smits
HAHazal R. Azizoglu
Hazal R. Azizoglu
SBSylvia Brugman
Sylvia Brugman
YBYoeri van de Burgt
Yoeri van de Burgt
HWHanneke L.D.M. Willemen
Hanneke L.D.M. Willemen
Chronic pain is an ill-defined disease with complex biopsychosocial aspects, posing treatment challenges. We hypothesized that treatment failure results, at least partly, from limited understanding of diverse patient subgroups. We aimed to identify subgroups using psychological variables, allowing for more tailored interventions. In a retrospective cohort study, we extracted patient-reported data from two Dutch tertiary multidisciplinary outpatient pain clinics (2018-2023) for unsupervised hierarchical clustering. Clusters were defined by anxiety, depression, pain catastrophizing, and kinesiophobia. Sociodemographics, pain characteristics, diagnosis, lifestyle, health-related quality of life and treatment efficacy were compared among clusters. A prediction model was built utilizing a minimum set of questions to reliably assess cluster allocation. Among 5,466 patients with chronic pain, three clusters emerged. Cluster 1 (n=750) was characterized by high psychological burden, low health-related quality of life, lower educational levels and employment rates, and more smoking. Cluster 2 (n=1,795) showed low psychological burden, intermediate health-related quality of life, higher educational levels and employment rates, and more alcohol consumption. Cluster 3 (n=2,909) showed intermediate features. Pain reduction following treatment was least in cluster 1 (28.6% after capsaicin patch, 18.2% after multidisciplinary treatment), compared to >50% for both treatments in clusters 2 and 3. A model incorporating 15 psychometric questions reliably predicted cluster allocation. In conclusion, our study identified distinct chronic pain patient clusters through 15 psychological questions, revealing one cluster with notably poorer response to conventional treatment. Our prediction model, integrated in a web-based tool, may help clinicians improve treatment by allowing patient-subgroup targeted therapy according to cluster allocation. PERSPECTIVE: Hierarchical clustering of chronic pain patients identified three subgroups with similar pain intensity and diagnoses but distinct psychosocial traits. One group with higher psychological burden showed poorer treatment outcomes. A web-based tool using this model could help clinicians tailor therapies by matching interventions to specific patient subgroups for improved outcomes.

1 July 2017 in Scandinavian Journal of Pain
Verified
Journal Article
Closed access
MRMienke Rijsdijk
Mienke Rijsdijk
NANilesh M. Agalave
Nilesh M. Agalave
AWAlbert J.M. van Wijck
Albert J.M. van Wijck
CKCornelis J. Kalkman
Cornelis J. Kalkman
RRRoshni Ramachandran
Roshni Ramachandran
TYTony L. Yaksh
Tony L. Yaksh
Background and aims: Despite widespread use, the efficacy of neuraxial glucocorticoids for neuropathic painis subject to debate. Since most glucocorticoid actions are mediated through its receptor, we explored the effects of intrathecal methylprednisolone acetate (MPA) on total glucocorticoid receptor (tGR) levels and activation of the glucocorticoid receptor (phosphorylated state = pGR) within the spinal dorsal horn (SDH) and dorsal root ganglion (DRG) in a spinal nerve ligation (SNL) model in rats. Methods: Rats received unilateral ligation of the L5/L6 spinal nerves and were treated with two intrathecal doses of either 400 μg MPA or 0.9% saline with a 72-h interval. Plantar tactile thresholds were measured over time. Seven days after drug treatment, DRG and SDH were harvested to assess tGR and pGR levels using immunohistochemistry and qPCR. Results: Allodynia, defined by lowered tactile withdrawal thresholds after SNL, was unaltered by intrathecal MPA. In saline controls, mRNA levels of tGR did not change after SNL in the DRGs or SDH. tGR and pGR protein levels in the SDH however, significantly increased on the ipsilateral side of SNL compared to the contralateral side and to naïve tissue. When treating rats with MPA, tGR mRNA levels were significantly reduced in the SDH compared to saline controls. tGR and pGR protein levels, however were not significantly lower compared to saline controls. Conclusions: In intrathecal MPA treated rats, tGR mRNA levels decreased after SNL. However this did not result in lower tGR and pGR protein levels compared to saline controls, and did not decrease ligation-induced mechanical hypersensitivity. Implications: Intrathecal MPA treatment after SNL did not result in lower tGR and pGR levels within the SDH and DRG compared to saline controls. In present study we did not differentiate between the various isoforms of the GR which might clarify this finding.